No Data
No Data
CCORF Initiates Celldex Therapeutics(CLDX.US) With Buy Rating, Announces Target Price $64
Celldex Therapeutics Price Target Announced at $64.00/Share by Canaccord Genuity
New Analyst Forecast: $CLDX Given $46.0 Price Target
This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Celldex Therapeutics Initiated at Overweight by Morgan Stanley
Morgan Stanley Initiates Celldex Therapeutics(CLDX.US) With Buy Rating, Announces Target Price $46